JP2010513320A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513320A5
JP2010513320A5 JP2009541645A JP2009541645A JP2010513320A5 JP 2010513320 A5 JP2010513320 A5 JP 2010513320A5 JP 2009541645 A JP2009541645 A JP 2009541645A JP 2009541645 A JP2009541645 A JP 2009541645A JP 2010513320 A5 JP2010513320 A5 JP 2010513320A5
Authority
JP
Japan
Prior art keywords
day
pirfenidone
days
pharmaceutical composition
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009541645A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513320A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/087988 external-priority patent/WO2008077068A1/en
Publication of JP2010513320A publication Critical patent/JP2010513320A/ja
Publication of JP2010513320A5 publication Critical patent/JP2010513320A5/ja
Pending legal-status Critical Current

Links

JP2009541645A 2006-12-18 2007-12-18 ピルフェニドン治療を患者に提供する方法 Pending JP2010513320A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87059306P 2006-12-18 2006-12-18
PCT/US2007/087988 WO2008077068A1 (en) 2006-12-18 2007-12-18 Method of providing pirfenidone therapy to a patient

Publications (2)

Publication Number Publication Date
JP2010513320A JP2010513320A (ja) 2010-04-30
JP2010513320A5 true JP2010513320A5 (https=) 2011-02-17

Family

ID=39259551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541645A Pending JP2010513320A (ja) 2006-12-18 2007-12-18 ピルフェニドン治療を患者に提供する方法

Country Status (14)

Country Link
US (9) US7767700B2 (https=)
EP (4) EP2338489B1 (https=)
JP (1) JP2010513320A (https=)
AT (1) ATE506060T1 (https=)
CA (1) CA2667654C (https=)
CY (1) CY1111699T1 (https=)
DE (1) DE602007014113D1 (https=)
DK (1) DK2124945T3 (https=)
ES (3) ES2395396T3 (https=)
MX (1) MX2009006526A (https=)
PL (2) PL3053580T3 (https=)
PT (1) PT2124945E (https=)
SI (1) SI2124945T1 (https=)
WO (1) WO2008077068A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2124945T1 (sl) 2006-12-18 2011-08-31 Intermune Inc Postopek dajanja terapije s pirfenidonom pacientu
US7566729B1 (en) 2008-11-10 2009-07-28 Intermune, Inc. Modifying pirfenidone treatment for patients with atypical liver function
US7635707B1 (en) * 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
AU2012205256B2 (en) * 2008-11-10 2015-05-28 Intermune, Inc. Pirfenidone Treatment for Patients with Atypical Liver Function
AU2010206543A1 (en) * 2009-01-26 2011-07-07 Intermune, Inc. Methods for treating acute myocardial infarctions and associated disorders
US7816383B1 (en) 2009-12-04 2010-10-19 Intermune, Inc. Methods of administering pirfenidone therapy
US8084475B2 (en) * 2009-12-04 2011-12-27 Intermune, Inc. Pirfenidone therapy and inducers of cytochrome P450
JP6021117B2 (ja) 2011-01-31 2016-11-02 ジェノア ファーマシューティカルズ，インク． エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
MX2011007675A (es) * 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
CA2819967C (en) * 2012-08-31 2016-03-22 Intermune, Inc. Use of pirfenidone concomitantly with ciprofloxacin
EP2968292A4 (en) 2013-03-15 2016-11-23 Intermune Inc METHOD FOR IMPROVING MICROVASCULAR INTEGRITY
USD731783S1 (en) 2014-04-16 2015-06-16 Abbvie Inc. Template for a prescription medicine container
USD731171S1 (en) 2013-10-07 2015-06-09 Abbvie Inc. Template for a prescription medicine container
USD731782S1 (en) 2013-10-07 2015-06-16 Abbvie Inc. Template for a prescription medicine container
NZ760541A (en) 2014-01-10 2022-08-26 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
US20190070145A1 (en) * 2016-03-22 2019-03-07 Mayo Foundation For Medical Education And Research Using fatty acid synthase inhibitors to treat fibrosis
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2019028062A1 (en) 2017-07-31 2019-02-07 Washington University PIRFENIDONE DERIVATIVES FOR MODULATION OF B-LYMPHOCYTE ACTIVITY AND PROTECTION OF ORGANS
USD930973S1 (en) 2018-03-22 2021-09-21 Abbvie Inc. Child-resistant medication container
USD930974S1 (en) 2018-03-22 2021-09-21 Abbvie Inc. Child-resistant medication container
US11052021B2 (en) 2018-03-22 2021-07-06 Abbvie Inc. Medicine container, method of assembling the container, and method of dispensing the medicine from the container
USD882243S1 (en) 2018-03-26 2020-04-28 Abbvie Inc. Child-resistant medication container assembly
US11406563B2 (en) * 2018-07-27 2022-08-09 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods
KR20220109439A (ko) 2019-12-04 2022-08-04 이도르시아 파마슈티컬스 리미티드 섬유증 질환의 치료에서 사용하기 위한 아제티딘 lpa1 수용체 길항제와 피르페니돈 및/또는 닌테다닙의 조합
GB2589635B (en) 2019-12-06 2021-12-01 Merxin Ltd Elongate form medicament carrier and medicament dispenser
WO2022194941A1 (en) * 2021-03-17 2022-09-22 Actelion Pharmaceuticals Ltd Pharmaceutical dosage system
CN119630395A (zh) 2022-02-28 2025-03-14 努福米克斯技术有限公司 用于治疗特发性肺纤维化的组合物和方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US695044A (en) * 1901-12-28 1902-03-11 Albert E Gibson Non-refillable bottle.
SE9502370D0 (sv) 1995-06-30 1995-06-30 Astra Ab Blister pack, especially for drugs, as well as method and device in manufacturing the same
US6956044B1 (en) * 2000-02-21 2005-10-18 Margolin Solomon B Compositions and methods for treatment of epilepsy
KR100891887B1 (ko) * 2001-01-29 2009-04-03 시오노기세이야쿠가부시키가이샤 5-메틸-1-페닐-2-(1ｈ)-피리돈을 활성 성분으로서 함유하는의약 제제
EP1551369A4 (en) * 2002-08-28 2007-05-09 Intermune Inc COMBINATION THERAPY FOR THE TREATMENT OF FIBROTIC DISEASES
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
US20070092488A1 (en) * 2003-05-16 2007-04-26 Intermune Inc. Methods of treating idiopathic pulmonary fibrosis
CN101039957A (zh) * 2003-05-16 2007-09-19 因特缪恩公司 合成的趋化因子受体配体及其使用方法
US20080025986A1 (en) * 2003-06-06 2008-01-31 Ozes Osman N Methods of Treating Tnf-Mediated Disorders
US20070053877A1 (en) * 2003-08-21 2007-03-08 Intermune, Inc. Methods of treating idiopathic pulmonary fibrosis
US7407973B2 (en) * 2003-10-24 2008-08-05 Intermune, Inc. Use of pirfenidone in therapeutic regimens
AU2006276246B2 (en) * 2005-07-25 2012-09-27 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis C virus replication
NZ591443A (en) 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
US20070203202A1 (en) * 2005-12-02 2007-08-30 Robinson Cynthia Y Methods of reducing adverse events associated with pirfenidone therapy
US20080003635A1 (en) * 2006-06-12 2008-01-03 Intermune, Inc. High Throughput Collagen Synthesis Assay
CN101484167B (zh) * 2006-06-15 2012-07-04 上海睿星基因技术有限公司 吡啶酮类衍生物预防和治疗放射性肺损伤的用途
RU2008152171A (ru) * 2006-07-05 2010-08-10 Интермьюн, Инк. (Us) Новые ингибиторы вирусной репликации гепатита с
SI2124945T1 (sl) 2006-12-18 2011-08-31 Intermune Inc Postopek dajanja terapije s pirfenidonom pacientu
US20080287508A1 (en) * 2007-05-18 2008-11-20 Intermune, Inc. Altering pharmacokinetics of pirfenidone therapy
WO2008144720A2 (en) * 2007-05-21 2008-11-27 University Of Washington Inhibitors of igf-1r signaling for the treatment of respiratory disorders

Similar Documents

Publication Publication Date Title
JP2010513320A5 (https=)
US20200113884A1 (en) Method of providing pirfenidone therapy to a patient
JP2015522630A5 (https=)
JP2013544290A5 (https=)
RU2013127423A (ru) Повышение биодоступности лекарственных средств при терапии налтрексоном
JP2009518293A5 (https=)
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
EP2747561A1 (en) Treatment of symptoms associated with female gastroparesis
JP2015518002A5 (https=)
EP2830605B1 (en) A combination medicament comprising phenylephrine and paracetamol
US8603523B2 (en) Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
JP2020511455A5 (https=)
JP2006508993A5 (https=)
JP2019535737A5 (https=)
HK1172827A (en) Method of providing pirfenidone therapy to a patient
HK1227319A1 (en) Method of providing pirfenidone therapy to a patient
HK1153647B (en) Method of providing pirfenidone therapy to a patient
HK1133584B (en) Method of providing pirfenidone therapy to a patient